Navigation Links
Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
Date:10/29/2008

red to placebo.(2)

-- The incidence of other potential lung infections (e.g., bronchitis) was generally higher for all active treatment groups, except SYMBICORT 80/4.5 mcg, compared to placebo.(2)

-- The most common drug-related adverse events were oral candidiasis, dysphonia, a voice disorder,(7) and headache.(2)

SUN Study Results (Abstracts 303 and 308)

The long-term efficacy and tolerability of SYMBICORT was assessed in a 12-month, randomized, double-blind, multicenter study evaluating 1,964 patients ages 40 years and older with moderate to very severe COPD.(3,4) After two weeks of treatment based on previous therapy (ICS and short-acting bronchodilators were allowed), patients were then randomized to receive twice-daily treatment with two inhalations of SYMBICORT pMDI 160/4.5 mcg, SYMBICORT pMDI 80/4.5 mcg, formoterol DPI 4.5 mcg or placebo.(3,4) Study results include:

-- SYMBICORT 160/4.5 mcg demonstrated significantly (P Less Than or Equal To .023) greater improvements from baseline in pre-dose FEV1 and one-hour post-dose FEV1 compared with formoterol.(3)

-- Improvements from baseline in morning and evening PEF were significantly (P Less Than or Equal To .017) greater for both SYMBICORT doses compared with formoterol and placebo.(3)

-- Exacerbation rates were significantly (P Less Than or Equal To .004) reduced by approximately 25-30 percent with both doses of SYMBICORT compared to formoterol and by approximately 40 percent compared to placebo.(3)

-- Both SYMBICORT doses demonstrated significantly (P<.038) greater improvements in BCSS (160/4.5 mcg only), sleep score, awakening-free nights (80/4.5 mcg only), and rescue medication use versus formoterol.(3)

-- Both doses of SYMBICORT were well-tolerated versus formoterol and placebo for up to 12 months.(4) The incidence of pneumonia-related adverse events were similar for all treatment arms compared to placebo.(4)

-- The incidence of other pote
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
2. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
3. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
4. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
5. Recruitment Completed in Ofatumumab NHL Pivotal Study
6. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
7. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
8. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
9. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
10. Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
11. First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... BEND, Ind. , Feb. 26, 2015  Mobility ... announce an agreement with Bank of America (NYSE: ... consumers nationwide to receive financing of the revolutionary MV-1 ... vehicle, designed from the ground up to provide safe ... Approved applicants can use their loan to purchase a ...
(Date:2/26/2015)... 26, 2015 LifeScienceIndustryResearch.com adds ... -In- Class Innovations and Cost Optimization Plays Major ... Pharmaceutical Companies research report to the pharmaceuticals intelligence ... this Global Pharma US & EU Outlook 2015 ... divestment of non-core assets result in healthy cash ...
(Date:2/26/2015)...  Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ... virus infections, today announced that Jonathan P. ... of Finance, a newly created role.  Mr. Freve ... including financial planning and reporting, accounting and risk ... , President and CEO. Mr. ...
Breaking Medicine Technology:Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2
...  Every newborn baby should enter this world healthy.  The people ... to doing their best to make sure this happens.  That,s ... corporate sponsor of March of Dimes March for Babies, for ... awareness of infant health issues and educate doctors and mothers-to-be ...
... the law firm of LeClairRyan as a shareholder in ... firm,s Alexandria, Va. and Washington, D.C. offices. ... attorney will provide compliance, internal investigations and representation on ... the Foreign Corrupt Practices Act (FCPA) and the UK ...
Cached Medicine Technology:Mission Pharmacal Is Proud to Sponsor March for Babies® 2Mission Pharmacal Is Proud to Sponsor March for Babies® 3Veteran FCPA and White Collar Attorney Michael Volkov Joins LeClairRyan 2
(Date:2/27/2015)... Muscular Dystrophy Association research grantee Charles ... University, recently announced a potentially game-changing advance in ... Duchenne muscular dystrophy (DMD). The results were published ... discuss their implications at MDA's 2015 Scientific Conference, ... , Background: Gersbach and team are investigating ...
(Date:2/27/2015)... 27, 2015 According to the report, ... China Dental Industry in 2013 rose by 31.9%. However, ... amount of revenue generated by the industry was recorded ... registered by the industry in 2013. , View ... has identified the oral industry as a branch of ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... Commuter Cities in Florida " report today. To ... the 2013 U.S. Census Bureau survey, considering only ... time of the survey. , The report visualizes ... methods of commuting and a breakdown of commute ...
(Date:2/27/2015)... 2015 On time and under budget, ... Hospital Joplin. Inside and out, the nearly 900,000-square-foot facility ... to replace the tornado-ravaged St. John’s Regional Medical Center ... is opening just 46 months after the tornado hit ... normally anticipate to plan, design and construct a similarly ...
(Date:2/27/2015)... The Radiology Business Management Association (RBMA) ... Fellows — one of the most highly regarded awards ... Since 2009, the RBMA Fellowship program has served to ... the Association and the profession. Fellow of the RBMA ... must meet a very high standard for educational accomplishment, ...
Breaking Medicine News(10 mins):Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2
... to expand GSK cardiovascular portfolio in US Acquisition ... provides sales, synergy ... /PRNewswire-,FirstCall/ -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK ) and ... which Reliant will be acquired by GSK for $1.65 billion ...
... Give More Than $7.2 Million and Volunteer, Thousands of ... the Country, ABBOTT PARK, Ill., Nov. 21 ... their neighbors, providing more than,$7.2 million in support for ... These employee contributions from the,company,s annual giving campaign are ...
... often deadly among older American women, doctors too often ... new report by a team of vascular surgeons from ... College campuses of NewYork-Presbyterian Hospital. , Much of that ... research has focused almost exclusively on males, so in ...
... Partnership to Create Enhanced, Customized Computer-Aided Detection ... Technology for GE ... 21 ,iCAD(R), Inc. (Nasdaq: ICAD ), an industry-leading ... division of,GE (NYSE: GE ), a manufacturer of ...
... a Web-based program that tracks pharmacy doses from order entry ... ... 21 Baxa Corporation has signed a,strategic reseller agreement with MedKeeper to ... sales and distribution rights for all worldwide healthcare,markets for the MedKeeper software., ...
... Nov. 21 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: ... written response from,the U.S. Food and Drug Administration ... for its once-daily tramadol formulation through,the Formal Dispute ... the Office of Drug Evaluation II, Center for ...
Cached Medicine News:Health News:GSK to Acquire Reliant Pharmaceuticals 2Health News:GSK to Acquire Reliant Pharmaceuticals 3Health News:GSK to Acquire Reliant Pharmaceuticals 4Health News:Abbott Employees Give Back to Local Communities This Holiday Season 2Health News:Abbott Employees Give Back to Local Communities This Holiday Season 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:GE Healthcare and iCAD enter into Developmental Agreement 2Health News:GE Healthcare and iCAD enter into Developmental Agreement 3Health News:GE Healthcare and iCAD enter into Developmental Agreement 4Health News:Baxa Corporation Signs Strategic Reseller Agreement With MedKeeper for Web-Based Productivity Tool 2Health News:Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: